Significant versus insignificant prostate cancer--can we identify the tigers from the pussy cats?

Editorial

L Boccon-Gibod. J Urol. 1996 Sep.

. 1996 Sep;156(3):1069-70.

doi: 10.1016/s0022-5347(01)65704-5.

No abstract available

Comment on

Pathological characteristics and prognosis of nonpalpable and palpable prostate cancers with a Hybritech prostate specific antigen of 4 to 10 ng./ml.
Geary ES, Stamey TA. Geary ES, et al. J Urol. 1996 Sep;156(3):1056-8. J Urol. 1996. PMID: 8709306
Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies.
Goto Y, Ohori M, Arakawa A, Kattan MW, Wheeler TM, Scardino PT. Goto Y, et al. J Urol. 1996 Sep;156(3):1059-63. J Urol. 1996. PMID: 8709307
Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy.
Bettencourt MC, Bauer JJ, Sesterhenn IA, Mostofi FK, McLeod DG, Moul JW. Bettencourt MC, et al. J Urol. 1996 Sep;156(3):1064-8. J Urol. 1996. PMID: 8709308